ConductScience.org, home

Paper39196152

Atherosclerosis antigens as targets for immunotherapy.

Raposo-Gutiérrez I and 2 others. Nat Cardiovasc Res, 2023. Cited by 16 papers, by iCite.

Cite this record

ConductScience Library. Atherosclerosis antigens as targets for immunotherapy. Papers, record 39196152. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39196152

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Atherosclerosis antigens as targets for immunotherapy.
PubMed
Journal
Nat Cardiovasc Res
PubMed
Year
2023
PubMed
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
16
iCite
Relative citation ratio, by iCite
1.19
iCite
Revised in PubMed
2025-11-14
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Raposo-Gutiérrez IIrene
2Rodríguez-Ronchel AAnahttps://orcid.org/0000-0003-1589-5831
3Ramiro ARAlmudena Rhttps://orcid.org/0000-0002-7539-3844

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AtherosclerosisMajor topic
Adaptive ImmunityMajor topic
ImmunotherapyMajor topic
Humans
Animals
B-Lymphocytes
Autoantigens
T-Lymphocytes

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
PID2019-106773RB-I00/AEI/10.13039/501100011033Ministerio de Economía, Industria y Competitividad, Gobierno de España (Ministerio de Economía, Industria y Competitividad)PubMed
HR22-0253"la Caixa" Foundation (Caixa Foundation)PubMed

Source PubMed

Download CSV of grants

References207

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
133309175Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study.J Am Coll Cardiol2020https://conductscience.org/library/papers/33309175PubMed
219302038Immune and inflammatory mechanisms of atherosclerosis (*).Annu Rev Immunol2009https://conductscience.org/library/papers/19302038PubMed
315843671Inflammation, atherosclerosis, and coronary artery disease.N Engl J Med2005https://conductscience.org/library/papers/15843671PubMed
49887164Atherosclerosis--an inflammatory disease.N Engl J Med1999https://conductscience.org/library/papers/9887164PubMed
511239408Atherosclerosis. the road ahead.Cell2001https://conductscience.org/library/papers/11239408PubMed
62648148Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity.N Engl J Med1989https://conductscience.org/library/papers/2648148PubMed
77667279Decreased atherosclerosis in mice deficient in both macrophage colony-stimulating factor (op) and apolipoprotein E.Proc Natl Acad Sci U S A1995https://conductscience.org/library/papers/7667279PubMed
823995626Macrophages in atherosclerosis: a dynamic balance.Nat Rev Immunol2013https://conductscience.org/library/papers/23995626PubMed
928392564The immunology of atherosclerosis.Nat Rev Nephrol2017https://conductscience.org/library/papers/28392564PubMed
1033883728The changing landscape of atherosclerosis.Nature2021https://conductscience.org/library/papers/33883728PubMed
1134389841How the immune system shapes atherosclerosis: roles of innate and adaptive immunity.Nat Rev Immunol2022https://conductscience.org/library/papers/34389841PubMed
1229716940Residual Inflammatory Risk on Treatment With PCSK9 Inhibition and Statin Therapy.Circulation2018https://conductscience.org/library/papers/29716940PubMed
1328845751Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.N Engl J Med2017https://conductscience.org/library/papers/28845751PubMed
1431733140Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction.N Engl J Med2019https://conductscience.org/library/papers/31733140PubMed
1532865380Colchicine in Patients with Chronic Coronary Disease.N Engl J Med2020https://conductscience.org/library/papers/32865380PubMed
1611457878Lymphocytes are important in early atherosclerosis.J Clin Invest2001https://conductscience.org/library/papers/11457878PubMed
1711397712Effect of immune deficiency on lipoproteins and atherosclerosis in male apolipoprotein E-deficient mice.Arterioscler Thromb Vasc Biol2001https://conductscience.org/library/papers/11397712PubMed
1832340571In Vivo CD4+ T Cell Differentiation and Function: Revisiting the Th1/Th2 Paradigm.Annu Rev Immunol2020https://conductscience.org/library/papers/32340571PubMed
1932203286T cell subsets and functions in atherosclerosis.Nat Rev Cardiol2020https://conductscience.org/library/papers/32203286PubMed
2016462800Natural regulatory T cells control the development of atherosclerosis in mice.Nat Med2006https://conductscience.org/library/papers/16462800PubMed

See all 207 referencesDownload CSV of references

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.

PMIDTitleJournalYearIn PapersSource
42941217Deciphering Vascular Smooth Muscle Cell Phenotype Switching via Integrated Single-Cell Transcriptomics and Machine Learning: CX3CR1 and COL1A1 as Novel Diagnostic Biomarkers for Atherosclerosis.Metabolites2026https://conductscience.org/library/papers/42941217PubMed
42927614BDH1 Attenuates Macrophage Foam Cell Formation and Inflammation in Atherosclerosis Via Modulating Histone H3K9 Acylation Balance and Activating PPAR Signaling.J Biochem Mol Toxicol2026https://conductscience.org/library/papers/42927614PubMed
42905940NSG Mice Lacking Apoe: An Immunodeficient Mouse Model of Atherosclerosis.FASEB J2026https://conductscience.org/library/papers/42905940PubMed
42888064Taming inflammation in coronary artery disease: lessons learned, translational breakthroughs, and future directions.Sci Bull (Beijing)2026https://conductscience.org/library/papers/42888064PubMed
42839935Yiqihuoxue formula improves atherosclerosis by regulating macrophage polarization associated with enhanced STAT6/PPARγ pathway.Front Cardiovasc Med2026https://conductscience.org/library/papers/42839935PubMed
42724038B cells and B-cell receptor repertoire features in coronary heart disease: immunopathogenic roles, clinical relevance, and therapeutic potential.Front Cardiovasc Med2026https://conductscience.org/library/papers/42724038PubMed
42706439Artery tertiary lymphoid organs encode a pathogenic high-affinity autoantibody-autoantigen pair in atherosclerosis.Nat Cardiovasc Res2026https://conductscience.org/library/papers/42706439PubMed
42549668Nanomaterials-Based Immunotherapy for Atherosclerosis.Small2026https://conductscience.org/library/papers/42549668PubMed
42510870Integrated Bioinformatics and Machine Learning Analysis Identifies Inflammation-Related Biomarkers and Immune Infiltration Patterns in Atherosclerosis.Genes (Basel)2026https://conductscience.org/library/papers/42510870PubMed
42303606Whole blood epigenomic and transcriptomic characterization identifies vulnerable molecular subtypes of chronic coronary disease.Nat Commun2026https://conductscience.org/library/papers/42303606PubMed
42112342Polymeric immunoglobulin receptor deficiency attenuates experimental atherosclerosis.Front Immunol2026https://conductscience.org/library/papers/42112342PubMed
42086715CD8+ T cells in atherosclerosis and coronary artery disease.Nat Rev Cardiol2026https://conductscience.org/library/papers/42086715PubMed
42001296T Cell Receptor Repertoires Across the Continuum of Vascular, Myocardial, and Age-Related Diseases.Immunol Rev2026https://conductscience.org/library/papers/42001296PubMed
41494534Restoring immune homeostasis in atherosclerotic plaques via inorganic violet phosphorus nano-immunotherapy.Cell Rep Med2026https://conductscience.org/library/papers/41494534PubMed
41484095Revitalizing T cells: breakthroughs and challenges in overcoming T cell exhaustion.Signal Transduct Target Ther2026https://conductscience.org/library/papers/41484095PubMed
40996881Tertiary Lymphoid Structures Across Organs: Context, Composition, and Clinical Levers.Immunol Rev2025https://conductscience.org/library/papers/40996881PubMed
40968356ALDH2 in autophagy and cell death: molecular mechanisms and implications for diseases.Mil Med Res2025https://conductscience.org/library/papers/40968356PubMed
40533521Loss of effector Treg signature in APOB-reactive CD4+ T cells in patients with coronary artery disease.Nat Cardiovasc Res2025https://conductscience.org/library/papers/40533521PubMed
40454002Mechanisms and implications of vascular-homing CD8 T cells in atherosclerosis.NPJ Cardiovasc Health2025https://conductscience.org/library/papers/40454002PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/39196152

GET https://conductscience.org/api/papers/v1/39196152/references?page=2